Samsung Bioepis Co., Ltd. (United States)

Samsung Bioepis is a South Korean biopharmaceutical company developing biosimilar products. The company manufactures and markets high-quality biosimilars to expensive biologic drugs including adalimumab, infliximab, etanercept, and trastuzumab. Samsung Bioepis’s biosimilars increase global patient access to life-changing biologic therapies while reducing healthcare costs.